You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Table 1

From: Pre-treatment patient selection for nivolumab benefit based on serum mass spectra

Set HR(TTP) Log-rank p-value HR(OS) Log-rank p-value
DEV 0.48 0.020 0.026 0.005
VAL 0.43 0.013 0.48 0.012
Full SET1 0.50 0.001 0.38 <0.001
SET2 n/a n/a 0.26 0.002